Adenoviral vector mediated gene transfer therapy for OTC deficiency
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Adenoviral vector mediated gene transfer therapy for OTC deficiency, covering 2015-03-25 to 2015-03-25. Get the full timeline:
Most recent: Clinical Trial Update: Phase I Study of Adenoviral Vector Mediated Gene Transfer for Ornithine Transcarbamylase in Adults With Partial Ornithine Transcarbamylase Deficiency [Phase 1]